🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rosai-Dorfman Disease (RDD) is a rare, heterogeneous histiocytic disorder. ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-06-08
Trial ID
NCT04924647
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
Recent prospective multicenter phase II study assessed the efficacy and tol...
Status
Unknown
Location
Kosin University Gospel Hospital
Start Date
2019-03-11
Trial ID
NCT03809780
Treatments Being Tested
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This randomized phase III trial compares ixazomib citrate, lenalidomide, de...
Status
Terminated
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-11-29
Trial ID
NCT02516423
Treatments Being Tested
The investigators propose this study utilizing Lenalidomide, Adriamycin, De...
Status
Unknown
Location
Universitätsklinikum Aachen, Med. Klinik IV, Hämatologie u. Onkologie
Start Date
2012-05
Trial ID
NCT01685814
Treatments Being Tested
Study Objectives 1. Evaluate the efficacy of the combination of thalidomid...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2007-10
Trial ID
NCT00538733
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
A phase 3, randomized, open-label, parallel-controlled, multi-center study ...
Status
Completed
Location
Capital Medical University (CMU) - Beijing Chao-Yang Hospital
Start Date
2019-03-27
Trial ID
NCT03952091
Treatments Being Tested